Douglas E. Giordano's most recent trade in Cerevel Therapeutics Holdings Inc was a trade of 10,461 Common Stock done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings | Douglas E. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 13,743 | - | - | Common Stock | |
| Cerevel Therapeutics Holdings | Douglas E. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Douglas E. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 3,282 | - | - | Common Stock | |
| Cerevel Therapeutics Holdings | Douglas E. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Douglas E. Giordano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 58,003 | 58,003 | - | - | Stock Option (Right to Buy) |